Literature DB >> 17965752

The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses.

R Pettipher1.   

Abstract

Prostaglandin D(2) (PGD(2)) is produced by mast cells, Th2 lymphocytes and dendritic cells and has been detected in high concentrations at sites of allergic inflammation. PGD(2) exerts its inflammatory effects through high affinity interactions with the G protein coupled receptors DP(1) and chemoattractant-homologous receptor expressed on Th2 cells (CRTH2, also known as DP(2)). DP(1) and CRTH2 act in concert to promote a number of biological effects associated with the development and maintenance of the allergic response. During the process of allergen sensitization, DP(1) activation may enhance polarization of Th0 cells to Th2 cells by inhibiting production of interleukin 12 by dendritic cells. Upon exposure to allergen in sensitized individuals, activation of DP(1) may contribute to the long lasting blood flow changes in the target organ. CRTH2 is expressed by Th2 lymphocytes, eosinophils and basophils and may mediate the recruitment of these cell types during the late phase allergic response. The role played by CRTH2 in promoting the production of Th2 cytokines and IgE make antagonism of this receptor a particularly attractive approach to the treatment of chronic allergic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965752      PMCID: PMC2268053          DOI: 10.1038/sj.bjp.0707488

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  92 in total

1.  Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy.

Authors:  W J Doyle; S Boehm; D P Skoner
Journal:  J Allergy Clin Immunol       Date:  1990-12       Impact factor: 10.793

2.  The comparative nasal effects of prostaglandin D2 in normal and rhinitic subjects.

Authors:  P Howarth; S Walsh; C Robinson
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

Review 3.  Nasal pathophysiology.

Authors:  J G Widdicombe
Journal:  Respir Med       Date:  1990-11       Impact factor: 3.415

4.  Selective expression of a novel surface molecule by human Th2 cells in vivo.

Authors:  K Nagata; K Tanaka; K Ogawa; K Kemmotsu; T Imai; O Yoshie; H Abe; K Tada; M Nakamura; K Sugamura; S Takano
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

5.  Effect of nedocromil sodium on allergen-, PAF-, histamine- and bradykinin-induced airways vasodilatation and pulmonary obstruction in the pig.

Authors:  K Alving; R Matran; J M Lundberg
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

6.  Prostanoid receptors involved in the relaxation of human pulmonary vessels.

Authors:  L Walch; C Labat; J P Gascard; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Prostaglandin D2 as a mediator of allergic asthma.

Authors:  T Matsuoka; M Hirata; H Tanaka; Y Takahashi; T Murata; K Kabashima; Y Sugimoto; T Kobayashi; F Ushikubi; Y Aze; N Eguchi; Y Urade; N Yoshida; K Kimura; A Mizoguchi; Y Honda; H Nagai; S Narumiya
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

8.  Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.

Authors:  E N Charlesworth; A Kagey-Sobotka; R P Schleimer; P S Norman; L M Lichtenstein
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

9.  The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.

Authors:  H Giles; P Leff; M L Bolofo; M G Kelly; A D Robertson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

10.  Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.

Authors:  S Hamid-Bloomfield; B J Whittle
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

View more
  46 in total

1.  Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection.

Authors:  Andreas Krause; Jochen Zisowsky; Daniel S Strasser; Martine Gehin; Patricia N Sidharta; Peter M A Groenen; Jasper Dingemanse
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

Review 2.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

3.  Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils.

Authors:  F P Mesquita-Santos; I Bakker-Abreu; T Luna-Gomes; P T Bozza; B L Diaz; C Bandeira-Melo
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.

Authors:  Abdullah Shafique Ahmad; Haneen Ottallah; Carolina B Maciel; Michael Strickland; Sylvain Doré
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

Review 5.  New therapies for allergic rhinitis.

Authors:  Fulvio Braido; Francesca Sclifò; Matteo Ferrando; Giorgio Walter Canonica
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

Review 6.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

7.  Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program.

Authors:  Silvana Balzar; Merritt L Fajt; Suzy A A Comhair; Serpil C Erzurum; Eugene Bleecker; William W Busse; Mario Castro; Benjamin Gaston; Elliot Israel; Lawrence B Schwartz; Douglas Curran-Everett; Charity G Moore; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

Review 8.  Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function.

Authors:  Joseph M Kulinski; Rosa Muñoz-Cano; Ana Olivera
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

9.  Role of prostaglandin D2 /CRTH2 pathway on asthma exacerbation induced by Aspergillus fumigatus.

Authors:  Haixia Liu; Mingrui Zheng; Jianou Qiao; Yajie Dang; Pengyu Zhang; Xianqiao Jin
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 10.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.